Scientific article
French

Dépistage néonatal systématique de la mucoviscidose en Suisse: dès janvier 2011

Published in

Revue médicale suisse, vol. 7, no. 283, p. 456,458-460

Publication date

2011

Abstract

The diagnosis of cystic fibrosis (CF) is often delayed because of the nonspecificity of a wide variety of clinical symptoms at disease onset. Newborn screening for CF has been advocated to reduce delays in diagnosis, facilitating preventive care for early respiratory and nutritional involvement. According to American and European consensus and experience of existing programs, a Swiss Nationwide Cystic Fibrosis Newborn Screening Program started in January 2011. Screening strategy combines two steps: an immunoreactive trypsinogen assay and DNA mutation analysis in dried blood samples at day 4 (Guthrie cards).

Keywords

  • Cystic Fibrosis/blood/diagnosis/genetics/prevention & control
  • DNA Mutational Analysis
  • Humans
  • Infant, Newborn
  • Neonatal Screening
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Switzerland
  • Trypsinogen/blood

Citation (ISO format)

MORNAND, Anne, BARBEN, Jürg, HAFEN, Gaudenz. Dépistage néonatal systématique de la mucoviscidose en Suisse: dès janvier 2011. In: Revue médicale suisse, 2011, vol. 7, n° 283, p. 456,458–460.

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://rms.medhyg.ch/numero-283-page-456.htm

Journal ISSN

1660-9379
574views
0downloads

Technical informations

Creation

18/12/2012 12:52:00

First validation

18/12/2012 12:52:00

Update

14/03/2023 19:58:55

Status update

14/03/2023 19:58:54

Last indexation

30/10/2024 08:33:53
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated